St. Johns Investment Management Company LLC Has $1.55 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

St. Johns Investment Management Company LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,646 shares of the healthcare conglomerate’s stock after selling 413 shares during the period. St. Johns Investment Management Company LLC’s holdings in UnitedHealth Group were worth $1,547,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in UNH. International Assets Investment Management LLC boosted its position in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Swedbank AB bought a new position in UnitedHealth Group during the first quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in UnitedHealth Group by 107.8% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC bought a new position in UnitedHealth Group during the second quarter worth $480,903,000. Finally, Dimensional Fund Advisors LP boosted its position in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.7 %

Shares of NYSE UNH opened at $564.56 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The company has a market cap of $521.33 billion, a price-to-earnings ratio of 36.78, a PEG ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The stock has a 50-day moving average price of $583.52 and a two-hundred day moving average price of $537.96.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 earnings per share. The firm’s revenue was up 9.2% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. Argus boosted their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Finally, Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.